Union Korea Pharm Delays New Stock Listing to July 22 in Capital Reduction Amendment
Union Korea Pharm amended its capital reduction report, postponing the new stock listing date from July 15 to July 22 due to procedural delays at the deposit-clearing agency.
The core terms of the rehabilitation plan remain unchanged, including the 66.67% reduction ratio, post-reduction shares of 19,854,006, and the cancellation of fractional shares.
The one-week delay is administrative and does not affect existing shareholder equity or the company's financial structure.
[AI Summary]The listing delay is a routine procedural adjustment with no impact on the fundamental terms of the capital reduction. Investors should focus on the upcoming third-party allotment and other capital structure changes rather than the minor schedule shift.
KOSDAQ Filing Information
[Correction of Description] Report on Major Matters (Decision on Capital Reduction)